Yu-Kyeong Hwang
Director/Board Member bij GC CELL CORPORATION
Profiel
Yu-Kyeong Hwang is currently the Director, Senior MD & Head-Research Institute at GC Cell Corp.
Prior to this, Dr. Hwang worked as a Director at GREEN CROSS CELL Corp.
and as a Director at Artiva Biotherapeutics, Inc. from 2019 to 2022.
Dr. Hwang completed their undergraduate degree at Indiana University.
Actieve functies van Yu-Kyeong Hwang
| Bedrijven | Functie | Begin |
|---|---|---|
| GC CELL CORPORATION | Director/Board Member | 01-09-2014 |
Eerdere bekende functies van Yu-Kyeong Hwang
| Bedrijven | Functie | Einde |
|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Director/Board Member | 01-04-2022 |
| GREEN CROSS CELL CORPORATION | Director/Board Member | - |
Opleiding van Yu-Kyeong Hwang
| Indiana University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GC CELL CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
GREEN CROSS CELL Corp.
 GREEN CROSS CELL Corp. BiotechnologyHealth Technology GREEN CROSS CELL Corp. engages in the provision of anti-cancer immunotherapy. It operates through the following businesses: Cancer Immunotherapy, Cord Blood Cryopreservation, and Other Services. The company was founded on September 17, 1992 and is headquartered in Yongin-si, South Korea. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
